PHH Stock Overview

An investment holding company, provides personalized skincare products in the People’s Republic of China. More details

PHH fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	2/6
Financial Health	6/6
Dividends	0/6

Risk Analysis

Revenue has declined by 11.3% over the past year

Shares are highly illiquid

Does not have meaningful revenue ($2M)

My Notes

Capture your thoughts, links and company narrative

Park Ha Biological Technology Co., Ltd. Competitors

FitLife Brands

NasdaqCM:FTLF

US$152.8m

Veru

NasdaqCM:VERU

US$93.0m

Medifast

NYSE:MED

US$189.5m

Paranovus Entertainment Technology

NasdaqCM:PAVS

US$87.9m

Price History & Performance

Summary of share price highs, lows and changes for Park Ha Biological Technology
Historical stock prices
Current Share Price	US$6.29
52 Week High	US$6.90
52 Week Low	US$3.70
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	54.55%

Recent updates

Shareholder Returns

	PHH	US Specialty Retail	US Market
7D	n/a	-0.4%	-1.1%
1Y	n/a	14.5%	22.4%

Return vs Industry: Insufficient data to determine how PHH performed against the US Specialty Retail industry.

Return vs Market: Insufficient data to determine how PHH performed against the US Market.

Price Volatility

Is PHH's price volatile compared to industry and market?
PHH volatility
PHH Average Weekly Movement	n/a
Specialty Retail Industry Average Movement	7.5%
Market Average Movement	6.3%
10% most volatile stocks in US Market	17.6%
10% least volatile stocks in US Market	3.1%

Stable Share Price: PHH's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine PHH's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2022	33	Xiaoqiu Zhang	parkha.cn

Park Ha Biological Technology Co., Ltd., an investment holding company, provides personalized skincare products in the People’s Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers private label skincare products, such as basic skin physical protection, exfoliation, sebum film repairing, surface microecological balance, and anti-aging products under the Park Ha brand, as well as customized skincare services.

Park Ha Biological Technology Co., Ltd. Fundamentals Summary

How do Park Ha Biological Technology's earnings and revenue compare to its market cap?
PHH fundamental statistics
Market cap	US$127.07m
Earnings (TTM)	US$401.15k
Revenue (TTM)	US$1.94m

410.8x

P/E Ratio

84.9x

P/S Ratio

Is PHH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PHH income statement (TTM)
Revenue	US$1.94m
Cost of Revenue	US$284.08k
Gross Profit	US$1.66m
Other Expenses	US$1.26m
Earnings	US$401.15k

Last Reported Earnings

Apr 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.015
Gross Margin	85.36%
Net Profit Margin	20.67%
Debt/Equity Ratio	0%

How did PHH perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/31 23:28
End of Day Share Price	2024/12/31 00:00
Earnings	2024/04/30
Annual Earnings	2023/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Park Ha Biological Technology Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

Park Ha Biological Technology NasdaqCM:PHH Stock Report